JNJ results have positive read-through for Legend Biotech (LEGN) - Barclays
Tweet Send to a Friend
Barclays analyst Gena Wang reiterated an Overweight rating and $94.00 price target on Legend Biotech Corp. (NASDAQ: LEGN) following a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
